Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago apartment REIT (NYSE: EQR) ~80,000 apartments; Q4 2024 EPS $1.10 (+34%), same-store NOI +3.1% in 2024, 2025 guidance 2.25-3.25% rev growth in Boston/NYC/Seattle/SF competing with AvalonBay.
Equity Residential is a Chicago, Illinois-based apartment real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: EQR) as an S&P 500 Real Estate component and member of the S&P 500 — owning and operating approximately 300 apartment communities with roughly 80,000 apartments concentrated in high-barrier-to-entry coastal and Sun Belt urban markets including Boston, New York, Washington D.C., Seattle, San Francisco Bay Area, Los Angeles, Denver, Atlanta, and Dallas through approximately 2,400 employees. In Q4 2024, Equity Residential reported earnings per share of $1.10 (versus $0.82 in Q4 2023, +34.1%), with full year 2024 same-store revenues increasing 3.0% and same-store net operating income (NOI) growing 3.1%. For 2025, the company provided guidance of 2.25%-3.25% same-store revenue growth, reflecting continued but moderating rent increases across its coastal and Sun Belt markets. Founded in 1966 by Sam Zell (who also founded Equity Commonwealth and other real estate enterprises), Equity Residential went public in 1993 and is managed by CEO Mark Parrell, who joined from Heitman Capital Management. The company's portfolio of professionally managed, amenity-rich apartment communities targets the affluent renter demographic — typically college-educated professionals earning $90,000-150,000 annually — who choose to rent in high-cost gateway cities rather than purchase.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.